Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2015 2
2017 5
2018 2
2019 2
2020 3
2021 6
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Shedding light on PRAME expression in dysplastic nevi: a cohort study.
Innocenti L, Scarpitta R, Corraro S, Ortenzi V, Bonadio AG, Loggini B, De Ieso K, Naccarato AG, Fanelli GN, Scatena C. Innocenti L, et al. Among authors: ortenzi v. Virchows Arch. 2023 Dec 19. doi: 10.1007/s00428-023-03720-5. Online ahead of print. Virchows Arch. 2023. PMID: 38112793
Vegetative Skin Lesions in Patient with Bruton's Agammaglobulinemia.
Fidanzi C, Margiotta FM, Bevilacqua M, Ortenzi V, Rocchi V, Granieri G, Romanelli M, Manni E. Fidanzi C, et al. Among authors: ortenzi v. Indian J Dermatol. 2023 Jul-Aug;68(4):490. doi: 10.4103/ijd.ijd_910_22. Indian J Dermatol. 2023. PMID: 37822391 Free PMC article. No abstract available.
Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case report.
Biancalana E, Ceccarini G, Magno S, Ortenzi V, Giannese D, Santini F, Solini A. Biancalana E, et al. Among authors: ortenzi v. Front Endocrinol (Lausanne). 2023 May 19;14:1172468. doi: 10.3389/fendo.2023.1172468. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37274321 Free PMC article.
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw.
Innocenti L, Ortenzi V, Scarpitta R, Montemurro N, Pasqualetti F, Asseri R, Lazzi S, Szumera-Cieckiewicz A, De Ieso K, Perrini P, Naccarato AG, Scatena C, Fanelli GN. Innocenti L, et al. Among authors: ortenzi v. Genes (Basel). 2023 Feb 15;14(2):501. doi: 10.3390/genes14020501. Genes (Basel). 2023. PMID: 36833428 Free PMC article.
Multiregional Sequencing of IDH-WT Glioblastoma Reveals High Genetic Heterogeneity and a Dynamic Evolutionary History.
Franceschi S, Civita P, Pasqualetti F, Lessi F, Modena M, Barachini S, Morelli M, Santonocito O, Vannozzi R, Pilkington GJ, Ortenzi V, Naccarato AG, Aretini P, Mazzanti CM. Franceschi S, et al. Among authors: ortenzi v. Cancers (Basel). 2021 Apr 23;13(9):2044. doi: 10.3390/cancers13092044. Cancers (Basel). 2021. PMID: 33922652 Free PMC article.
Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy.
Pasqualetti F, Gonnelli A, Orlandi P, Palladino E, Giannini N, Gadducci G, Mattioni R, Montrone S, Calistri E, Mazzanti CM, Franceschi S, Ortenzi V, Scatena C, Zavaglia K, Fanelli GN, Morganti R, Santonocito O, Bocci G, Naccarato AG, Paiar F. Pasqualetti F, et al. Among authors: ortenzi v. Invest New Drugs. 2021 Aug;39(4):1166. doi: 10.1007/s10637-021-01097-3. Invest New Drugs. 2021. PMID: 33704622 No abstract available.
26 results